Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

MHLW (Japan) approves Lunsumio (mosunetuzumab) to treat r/r follicular lymphoma – Chugai Pharma

Written by | 27 Mar 2025

Chugai Pharmaceutical Co., Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for Lunsumio for intravenous infusion 1mg” and “Lunsumio… read more.

New and updated data for Roche’s fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma – Roche

Written by | 11 Mar 2025

Roche announced that new and updated data from its industry-leading CD20xCD3 T-cell-engaging bispecific antibody programme were presented at the 66th American Society of Hematology (ASH) Annual Meeting &… read more.

EU gives green light for four new medicines

Written by | 1 May 2022

The European Medicine Agency’s key expert body – the Committee for Medicinal Products for Human Use (CHMP) – has recommended that four medicines be approved in the EU…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.